Galderma

Swiss pharmaceutical company Galderma S.A.TypePublicTraded asSIX: GALDIndustryDermatologyPharmaceuticalsFounded1981; 45 years ago (1981) (as a joint venture between L'Oréal and Nestlé)HeadquartersZug, SwitzerlandKey peopleFlemming Ørnskov (CEO)Thomas Ebeling (chairman)Revenue US$4.41 billion (2024)OwnerConsortium led by EQT AB (2019–2024)Nestle (1981–2019)L'Oréal (1981–2014)Number of employees6,500 (2024)Websitegalderma.com Galderma S.A. is a Swiss pharmaceutical company based in Zug that specializes in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it was acquired by a consortium of private institutional investors in 2019 and remained under their ownership until its initial public offering in 2024. Galderma was formed in 1981 as a joint venture between Nestlé and L'Oréal, and later became a wholly owned subsidiary of Nestlé. The company, headed by president and CEO Flemming Ørnskov (ex-Shire), has 33 sites in 100 countries with a worldwide network of distributors and employs more than 4,600 people. History The origins of Galderma date back to 1961 and the founding of the Owen dermatology company in Dallas, Texas, USA